Publications

D.I. Brixner, P. Lauper. Global Pharmacoeconomics: Impact on the U.S. Managed Care Market, Academy of Managed Care Pharmacy Annual Meeting, October, 1995.

D.I. Brixner, A.-P. Holtorf. Pharmaceutical Manufacturer's Role in Disease Management, University of Arizona Conference: Disease Management - Fact or Fantasy, January, 1996.

J. Duchane, D.I. Brixner, B. Growboski, M. Gunter. Identification of Patients with Seizure Disorders in a Managed Care Setting, Association of Pharmacoeconomics and Outcomes Research, April, 1997.

D.I. Brixner, R. Sasane, W.Goodwin. Step Analysis of Patients Initiated on ACEI or CCB Therapy in a Managed Care Setting, Academy of Managed Care Pharmacy Annual Meeting, May, 1997.

D.I. Brixner, O. Shoheiber, C. Polino, C. Lin. Analysis of Compliance across Four Therapeutic Drug Classes in a Pharmacy Claims Database, Academy of Managed Care Pharmacy Annual Meeting, May, 1997.

D.I. Brixner. Pharmacoeconomics and Outcomes Research in the Pharmaceutical Industry, Journal of Managed Care Pharmacy, February 1996.

D.I. Brixner, Scott Bull. Monoclonal Antibodies in the Changing Health Care Environment; American Journal of Managed Care, June 1997.

G. J. Okano, K.L Rascati, J.P. Wilson, D.D. Remund, J.D. Grabenstein, D.I. Brixner. Patterns of antihypertensive use among patients in the US Department of Defense Database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker. Clinical Therapeutics, (1997) 19(6), 1433-1445.

M. Wilson, J Patwell, O. Shoheiber, J. Eicher, D.I. Brixner, et-al. Clinical and economic implications of drug utilization patterns in the treatment of hypertension with ACE inhibitors and calcium channel blockers in a managed care setting. Journal of Managed Care Pharmacy (1998) 4 (March-April), 194-202.

L.C. Vermeulen, P.A. Windisch, R.J. Rydman, R.H. Bruskiewitz, D.I. Brixner, P.H. Vlasses. Using a multihospital systems framework to evaluate and extablish drug use policy. Journal of Medical Systems, (2002) 24(4), 235-246.

D.I. Brixner. Biotechnology Products: An Overview in "Biotechnology and Pharmacy" John M. Pezzuto, Michael E. Johnson, Henri R. Manassee, Eds., (1993) Chapman and Hall Publishers, New York.

D.I. Brixner, S. Szeinbach, H. Shah, S. Mehta, S. Ryu. Pharmacoeconomic Research in Managed Care in "Managed Care and Pharmacoeconomics" Robert Navarro, Ed. (July, 1999) Aspen Publishers, New York.

D.I. Brixner, P. Pochtar, J.E. Talbott. Pharmacoeconomics in "Making Sense of Managed Care Volume II: Strategic Positioning" K.A. Miller, E.K. Miller, Eds., (1997) Jossey-Bass Publishers, San Francisco, CA.

Patent: G. Sivam, M.W. Reed, A. Srinivasan, A.C. Morgan, D.I. Brixner, V.M. Vrudhula and F.T. Comezoglu. Targeting Substance - Diagnostic - Therapeutic Agent Conjugates Having Schiff Base Linkages. Patent Issued August 27, 1996 (US 5549883). Rights assigned to NeoRx Corporation, Seattle, WA 98119.

Go To...

• Profile
• Publications
• Courses Taught